1,594
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The case for ring vaccinations with special consideration of oral cholera vaccines

ORCID Icon & ORCID Icon
Pages 2069-2074 | Received 19 Mar 2018, Accepted 21 Mar 2018, Published online: 11 May 2018

References

  • Greenhalgh D. Optimal control of an epidemic by ring vaccination. Commun Stat Stoch Models. 1986;2(3):339–63. doi:10.1080/15326348608807041.
  • Wells CR, Tchuenche JM, Meyers LA, Galvani AP, Bauch CT. Impact of imitation processes on the effectiveness of ring vaccination. Bull Math Biol. 2011;73(11):2748–72. Epub 2011/03/17. doi:10.1007/s11538-011-9646-4. PMID:21409511.
  • Henderson DA. The eradication of smallpox–an overview of the past, present, and future. Vaccine. 2011;29(Suppl 4):D7–9. Epub 2011/12/23. doi:10.1016/j.vaccine.2011.06.080. PMID:22188929.
  • Lane JM. Mass vaccination and surveillance/containment in the eradication of smallpox. Curr Topics Microbiol Immunol. 2006;304:17–29. Epub 2006/09/23. PMID:16989262.
  • Hopkins JW. The eradication of smallpox: organizational learning and innovation in international health administration. J Dev Areas. 1988;22(3):321–32. PMID:12342353.
  • Strassburg MA. The global eradication of smallpox. Am J Infect Control. 1982;10(2):53–9. Epub 1982/05/01. doi:10.1016/0196-6553(82)90003-7. PMID:7044193.
  • In: Knobler S, Lederberg J, Pray LA, editors. Considerations for Viral Disease Eradication: Lessons Learned and Future Strategies: Workshop Summary. Washington (DC): The National Academies Collection: Reports funded by National Institutes of Health; 2002.
  • Greenwood BM, Hassan-King M, Whittle HC. Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Br Med J. 1978;1(6123):1317–9. doi:10.1136/bmj.1.6123.1317. PMID:417754.
  • Trotter CL, Lingani C, Fernandez K, Cooper LV, Bita A, Tevi-Benissan C, Ronveaux O, Préziosi MP, Stuart JM. Impact of MenAfriVac in nine countries of the African meningitis belt, 2010–15: an analysis of surveillance data. Lancet Infect Dis. 2017;17(8):867–72. doi:10.1016/S1473-3099(17)30301-8. PMID:28545721.
  • Levine H, Rishpon S, Huerta-Hartal M, Davidovitch N. Preventing mumps outbreaks in confined settings: comprehensive ring vaccination as a containment strategy. Hum Vaccin. 2011;7(12):1389–93. Epub 2011/11/24. doi:10.4161/hv.7.12.18111. PMID:22108037.
  • Pegorie M, Shankar K, Welfare WS, Wilson RW, Khiroya C, Munslow G, Fiefield D, Bothra V, McCann R. Measles outbreak in Greater Manchester, England, October 2012 to September 2013: epidemiology and control. Euro Surveill. 2014;19(49):20982. PMID:25523970.
  • Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet (London, England). 2015;386(9996):857–66. Epub 2015/08/08. doi:10.1016/S0140-6736(15)61117-5. PMID:26248676.
  • Ebola ça suffit ring vaccination trial consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ (Clinical Research Ed). 2015;351:h3740. Epub 2015/07/29. PMID:26215666.
  • WHO. Contact tracing during an outbreak of Ebola virus disease. http://www.who.int/csr/resources/publications/ebola/contacttracing-during-outbreak-of-ebola.pdf 2014.
  • Heymann DL, Aylward RB. Mass vaccination: when and why. Curr Topics Microbiol Immunol. 2006;304:1–16. Epub 2006/09/23. PMID:16989261.
  • Kaplan EH, Craft DL, Wein LM. Emergency response to a smallpox attack: the case for mass vaccination. Proc Natl Acad Sci U S A. 2002;99(16):10935–40. doi:10.1073/pnas.162282799. PMID:12118122.
  • Kucharski AJ, Eggo RM, Watson CH, Camacho A, Funk S, Edmunds WJ. Effectiveness of ring vaccination as control strategy for ebola virus disease. Emerging Infect Dis. 2016;22(1):105–8. Epub 2015/12/23. doi:10.3201/eid2201.151410. PMID:26691346.
  • Parker DM, Landier J, von Seidlein L, Dondorp A, White L, Hanboonkunupakarn B, Maude RJ, Nosten FH. Limitations of malaria reactive case detection in an area of low and unstable transmission on the Myanmar-Thailand border. Malar J. 2016;15(1):571. doi:10.1186/s12936-016-1631-9. PMID:27887652.
  • Grassly NC. The final stages of the global eradication of poliomyelitis. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623):20120140. Epub 2013/06/27. doi:10.1098/rstb.2012.0140. PMID:23798688.
  • Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev. 2000;22(2):298–316. doi:10.1093/oxfordjournals.epirev.a018041. PMID:11218380.
  • Eichner M, Dietz K. Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? Am J Epidemiol. 1996;143(8):816–22. doi:10.1093/oxfordjournals.aje.a008820. PMID:8610692.
  • GPEI. Responding to a polio virus outbreak: Standard Operating Procedures for a ne polio outbreak in a polio-free country. http://www.polioeradication.org/Portals/0/Document/Resources/PolioEradicators/1a.PolioOutbreakGuideline20150220.pdf 2015.
  • Martin S, Costa A, Perea W. Stockpiling oral cholera vaccine. Bull World Health Organ. 2012;90(10):714. doi:10.2471/BLT.12.112433. PMID:23109735.
  • Deployments from the oral cholera vaccine stockpile, 2013–2017. Wkly Epidemiol Rec. 2017;92(32):437–42. PMID:28799734.
  • Desai SN, Pezzoli L, Martin S, Costa A, Rodriguez C, Legros D, Perea W. A second affordable oral cholera vaccine: implications for the global vaccine stockpile. Lancet Global Health. 2016;4(4):e223–4. doi:10.1016/S2214-109X(16)00037-1. PMID:27013303.
  • You YA, Ali M, Kanungo S, Sah B, Manna B, Puri M, Nair GB, Bhattacharya SK, Convertino M, Deen JL, et al. Risk map of cholera infection for vaccine deployment: the eastern Kolkata case. PloS One. 2013;8(8):e71173. doi:10.1371/journal.pone.0071173. PMID:23936491.
  • Luquero FJ, Banga CN, Remartinez D, Palma PP, Baron E, Grais RF. Cholera epidemic in Guinea-Bissau (2008): the importance of “place”. PloS One. 2011;6(5):e19005. doi:10.1371/journal.pone.0019005. PMID:21572530.
  • Weil AA, Khan AI, Chowdhury F, Larocque RC, Faruque AS, Ryan ET, Calderwood SB, Qadri F, Harris JB. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009;49(10):1473–9. doi:10.1086/644779. PMID:19842974.
  • Mosley WH, Ahmad S, Benenson AS, Ahmed A. The relationship of vibriocidal antibody titre to susceptibility to cholera in family contacts of cholera patients. Bulletin World Health Organization. 1968;38(5):777–85. PMID:5303331.
  • Ali M, Debes AK, Luquero FJ, Kim DR, Park JY, Digilio L, Manna B, Kanungo S, Dutta S, Sur D, et al. Potential for controlling cholera using a ring vaccination strategy: Re-analysis of data from a cluster-randomized clinical trial. PLoS Med. 2016;13(9):e1002120. doi:10.1371/journal.pmed.1002120. PMID:27622507.
  • Sugimoto JD, Koepke AA, Kenah EE, Halloran ME, Chowdhury F, Khan AI, LaRocque RC, Yang Y, Ryan ET, Qadri F, et al. Household transmission of Vibrio cholerae in Bangladesh. PLoS Neglected Tropical Dis. 2014;8(11):e3314. doi:10.1371/journal.pntd.0003314. PMID:25411971.
  • Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, et al. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. The American Journal Of Tropical Medicine And Hygiene. 2014;91(4):738–42. doi:10.4269/ajtmh.14-0095. PMID:25114012.
  • Ley B, Khatib AM, Thriemer K, von Seidlein L, Deen J, Mukhopadyay A, Chang NY, Hashim R, Schmied W, Busch CJ, et al. Evaluation of a rapid dipstick (Crystal VC) for the diagnosis of cholera in Zanzibar and a comparison with previous studies. PLoS One. 2012;7(5):e36930. doi:10.1371/journal.pone.0036930. PMID:22662131.
  • Lopez AL, Deen J, Azman AS, Luquero FJ, Kanungo S, Dutta S, von Seidlein L, Sack DA. Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: a systematic review and meta-analysis. Clin Infect Dis. 2017. doi:10.1093/cid/cix1039. [Epub ahead of print]
  • Finger F, Bertuzzo E, Luquero FJ, Naibei N, Toure B, Allan M, Porten K, Lessler J, Rinaldo A, Azman AS. The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study. PLoS Medicine. 2018;15(2):e1002509. doi:10.1371/journal.pmed.1002509. PMID:29485987.
  • Azman AS, Parker LA, Rumunu J, Tadesse F, Grandesso F, Deng LL, Lino RL, Bior BK, Lasuba M, Page AL, et al. Effectiveness of one dose of oral cholera vaccine in response to an outbreak: a case-cohort study. Lancet Glob Health. 2016;4(11):e856–e63. doi:10.1016/S2214-109X(16)30211-X. PMID:27765293.
  • United Nations Office for the Coordination of Humanitarian Affairs (OCHA). Cholera cases increase. Humanitarian Bulletin South Sudan http://reliefweb.int/sites/reliefweb.int/files/resources/160808_OCHA_SouthSudan_humanitarian_bulletin_11.pdf Accessed 4 December 2017.
  • Troeger C, Sack DA, Chao DL. Evaluation of targeted mass cholera vaccination strategies in Bangladesh: A demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg. 2014;91(6):1181–9. doi:10.4269/ajtmh.14-0159. PMID:25294614.